The efficiency of acute infection of CD4+ T cells is markedly enhanced in the setting of antigen-specific immune activation

Journal of Experimental Medicine

Volumn 183, Issue 2, 1996, Pages 687-692

  Weissman, Drew ^a   Barker, Tobias D ^a   Fauci, Anthony S ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; TETANUS TOXOID;

ANTIGEN SPECIFICITY; ARTICLE; B LYMPHOCYTE ACTIVATION; CONTROLLED STUDY; DENDRITIC CELL; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNIZATION; IMMUNOSTIMULATION; LYMPHOCYTE PROLIFERATION; NORMAL HUMAN; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

ANTIGEN PRESENTATION; CD4-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; DENDRITIC CELLS; HIV; HIV INFECTIONS; HUMANS; IMMUNIZATION; LYMPHOCYTE ACTIVATION; TETANUS TOXOID;

EID: 0030026189     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.183.2.687     Document Type: Article

References (33)

1. Fauci, A.S. 1993. Multifactorial nature of human immunodeficiency virus disease: implications for therapy. Science (Wash. DC). 262:1011-1018.
2. Sheppard, H.W., and M.S. Ascher. 1992. The natural history and pathogenesis of HIV infection. Annu. Rev. Microbiol. 46: 533-564.
3. Folks, T.M., J. Kelly, S. Benn, A. Kinter, J. Justement, J. Gold, R. Redfield, K.W. Sell, and A.S. Fauci. 1986. Susceptibility of normal human lymphocytes to infection with HTLV III/LAV. J. Immunol. 136:4049-4053.
4. McDougal, J.S., A. Mawle, S.P. Cort, J.K.A. Nicholson, G.D. Cross, J.A. Scheppler-Cambell, D. Hicks, and J. Sligh. 1985. Cellular tropism of the human retrovirus HTLV-III/ LAV I: role of T cell activation and expression of the T4 antigen. J. Immunol. 135:3151-3162.
5. Bukrinsky, M.I., T.L. Stanwick, M.P. Dempsey, and M. Stevenson. 1991. Quiescent T lymphocytes as an inducible virus reservoir in HIV-1 infection. Science (Wash. DC). 254: 423-427.
6. Zagury, D., J. Bernard, R. Leonard, R. Cheynier, M. Feldman, P.S. Sarin, and R.C. Gallo. 1986. Long-term cultures of HTLV-III-infected T cells: a model of cytopathology of T-cell depletion in AIDS. Science (Wash. DC). 231:850-853.
7. Zack, J.A., S.J. Amgo, S.R. Weitsman, A.S. Go, A. Haislip, and I.S. Chen. 1990. HIV-1 entry into quiescent primary lymphocytes: molecular analysis reveals labile, latent viral structure. Cell. 61:213-222.
8. Aukrust, P., N.B. Liabakk, F. Muller, E. Lien, T. Espevik, and S.S. Froland. 1994. Serum levels of tumor necrosis factor-alpha (TNF alpha) and soluble TNF receptors in human immunodeficiency virus type 1 infection: correlations to clinical, immunologic, and virologic parameters. J. Infect. Dis. 169:420-424.
9. Bass, H.Z., P. Nishaman, W.D. Hardy, R.T. Mitsuyasu, E. Esmail, W. Cumberland, and J.L. Fahey. 1992. Immune changes in HIV-1 infection: significant correlations and differences in serum markers and lymphoid phenotypic antigens. Clin. Immunol. Immunopathol. 64:63-70.
10. Fahey, J.L., J.M. Taylor, R. Detels, B. Hofmann, R. Melrned, P. Nishanian, and J.V. Giorgi. 1990. The prognostic value of cellular and serologic markers in infection with human immunodeficiency virus type 1. N. Engl. J. Med. 322:166-172.
11. Gilks, C.F. 1993. The clinical challenge of the HIV epidemic in the developing world. Lancet. ii. 342:1037-1039.
12. Quinn, T.C. 1995. The epidemiology of the acquired immunodeficiency syndrome in the 1990s. Emerg. Med. Clin. North Am. 13:1-25.
13. Medley, G.F., R.M. Anderson, D.R. Cox, and I.L. Billard. 1987. Incubation period of AIDS in patients infected via blood transfusion. Nature (Lond.). 328:719-721.
14. Bentwich, Z., A. Kalinkovich, and Z. Weisman. 1995. Immune activation is a dominant factor in the pathogenesis of African AIDS. Immunol. Today. 16:187-191.
15. Ho, D.D., A.U. Neumann, A.S. Perelson, W. Chen, J.M. Leonard, and M. Markowitz. 1995. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature (Lond.). 373:123-126.
16. Wei, X., S.K. Ghosh, M.E. Taylor, V.A. Johnson, E.A. Emini, P. Deutsch, J.D. Lifson, S. Bonhoeffer, M.A. Nowak, B.H. Hahn, et al. 1995. Viral dynamics in human immunodeficiency virus type 1 infection. Nature (Lond.). 373:117-122.
17. Cheynier, R., S. Henrichwark, F. Hadida, E. Pelletier, E. Oksenhendler, B. Autran, and S. Wain-Hobson. 1994. HIV and T cell expansion in splenic white pulps is accompanied by infiltration of HIV-specific cytotoxic T lymphocytes. Cell. 78:373-387.
18. Pantaleo, G., C. Graziosi, J.F. Demarest, L. Butini, M. Montroni, C.H. Fox, J M. Orenstein, D.P. Kotler, and A.S. Fauci. 1993. HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease. Nature (Lond.) 362:355-358.
19. Embretson, J., M. Zupancic, J.L. Ribas, A. Burke, P. Racz, K. Tenner-Racz, and A.T. Haase. 1993. Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS. Nature (Lond.). 362: 359-362.
20. Weissman, D., Y. Li, J.M. Orenstein, and A.S. Fauci. Both a precursor and a mature population of dendritic cells can bind HIV; however, only the mature population that expresses CD80 can pass infection to unstimulated CD4 positive T cells. J. Immunol 155:4111-4117.
21. Lehner, T., L. Hussain, J. Wilson, and M. Chapman. 1991. Mucosal transmission of HIV. Nature (Lond.). 253:709.
22. Schmitt, D., and C. Dezutter-Dambuyant. 1994. Epidermal and mucosal dendritic cells and HIV-1 infection. Pathol. Res. Pract. 190:955-959.
23. Pope, M., M.G. Betjes, N. Romani, H. Hirmand, P.U. Cameron, L. Huffman, S. Gezelter, G. Schuler, and R.M. Stemman. 1994. Conjugates of dendritic cells and memory T lymphocytes from skin facilitate productive infection with HIV-1. Cell. 78:389-398.
24. Steinman, R.M. 1991. The dendritic cell system and its role in immunogenicity. Annu. Rev. Immunol. 9:271-298.
25. Weissman, D., Y. Li, J. Ananworanich, L.-J. Zhou, J. Adelsberger, T.F. Tedder, M. Baseler, and A.S. Fauci. 1995. Three populations of cells with dendritic morphology exist in peripheral blood, only one of which is infectable with human immunodeficiency virus type 1. Proc. Natl. Acad. Sci. USA. 92:826-830.
26. Palestine, A.G., F. Roberge, B.L. Charous, H.C. Lane, A.S. Fauci, and R.B. Nussenblatt. 1985. The effect of cyclosporine on immunization with tetanus and keyhole limpet hemocyanin (KLH) in humans. J. Clin. Immunol. 5:115-121.
27. Claydon, E.J., J. Bennett, D. Gor, and S.M. Forster. 1991. Transient elevation of serum HIV antigen levels associated with intercurrent infection. AIDS. 5:113-114.
28. Fultz, P.N., J.-C. Gluckman, E. Muchmore, and M. Girard. 1992. Transient increases in numbers of infectious cells in an HIV-infected chimpanzee following immune stimulation. AIDS Res. Hum. Retroviruses. 8:313-317.
29. Ho, D. 1992. HIV-1 viraemia and influenza. Lancet, i. 33: 1549.
30. O'Brien, W.A., K. Grovit-Ferbas, A. Namazi, S. Ovcak-Derzic, H.-J. Wang, J. Park, C. Yeramian, S.-H. Mao, and J.A. Zack. 1995. Human immunodeficiency virus-type 1 replication can be increased in peripheral blood of seropositive patients after influenza vaccination. Blood. 86:1082-1089.
31. smmPBj14: correlation between in vitro and in vivo events. J. Virol. 68:5538-5547.
32. Andrieu, J.M., P. Even, A. Venet, J.M. Tourani, M. Stern, W. Lowenstein, C. Audroin, D. Eme, D. Masson, H. Sors, et al. 1988. Effects of cyclosporin on T-cell subsets in human immunodeficiency virus disease. Clin. Immunol. Immunopathol. 47:181-198.
33. Andrieu, J.M , W. Lu, and R. Levy. 1995. Sustained increases in CD4 cell counts in asymptomatic human immunodeficiency virus type 1-seropositive patients treated with predmsolone for 1 year. J. Infect. Dis. 171:523-530.